所属领域：
抗突发性传染病药物研发
资源类型：
指南法规
/ 中国
文献作者：
Y. Saito, L. K. Stamp, K. E. Caudle, M. S. Hershfield, E. M. McDonagh, J. T. Callaghan, W. Tassaneeyakul, T. Mushiroda, N. Kamatani, B. R. Goldspiel, E. J. Phillips, T. E. Klein and M. T. Lee
文献发表年份：
2016
文献期刊：
Clin Pharmacol Ther
文献摘要： The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B*58:01 Genotype and Allopurinol Dosing was originally published in February 2013. We reviewed the recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the Supplemental Material and included additional resources for applying CPIC guidelines into the electronic health record. Up-to-date information can be found at PharmGKB (http://www.pharmgkb.org).
